User name

Don't have a user name yet?
Register here.


Incoming Lek CEO: Cost Cutting Chance for Generics Makers

Ljubljana, 10 April - Vojmir Urlep, the incoming chairman of pharma company Lek, believes that cost cutting measures by the health purse could benefit makers of generic drugs. Sales of generics are on the rise, Urlep says in an interview for daily Delo's financial supplement on Tuesday.

The rest of this news item is available to subscribers.
The news item consists of 945 characters (without spaces) or 195 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2007